Access cutting-edge non-small cell lung cancer treatment through this clinical trial at a research site in Colorado Springs. Study-provided care at no cost to qualified participants.
Access non-small cell lung cancer specialists in Colorado Springs at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-small cell lung cancer treatment provided free
The purpose of this study is to assess the safety and efficacy of divarasib compared to locally approved KRAS G12C inhibitors (sotorasib or adagrasib) in participants with KRAS G12C-positive (KRAS G12C +) advanced or metastatic non-small cell lung cancer (NSCLC).
Sponsor: Hoffmann-La Roche
Check if you qualify for this non-small cell lung cancer clinical trial in Colorado Springs, CO
If you're searching for non-small cell lung cancer treatment options in Colorado Springs, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Colorado Springs research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.